Premiere Facelift Specialist David Santos, MD, FACS
Call Us: 425-227-4000 12301 NE 10th Place Suite 101 Bellevue, WA 98005

« Back to Blog

Category: In the News

Injectables may help delay plastic surgery

Injectables may help delay plastic surgery.f


It would be smart to discuss this issue with the cosmetic company prior to the procedure and come to an agreement. This would have avoided the problem. Perhaps she could have gotten it done without the reality tv cameras, and avoid potentially loosing her endorements.

Article from below here


Kris Jenner says the cosmetics company she endorses has NO RIGHT to sue her for getting plastic surgery back in June … because the procedure didn’t affect her face … it just tightened up some loose neck skin.

The company in question — called B&P — sued Jenner earlier this week, claiming she breached a contract to endorse a line of their anti-aging skin care products … when the famous mother publicly admitted to getting a facelift.

By doing so, B&P alleges, Jenner violated her agreement not to harm the reputation of the company and the product she’s endorsing — an eye care line called “Beautiful Eyes in a Bag.”

But sources close to the Kardashian Klan tell TMZ, Kris is adamant … the lawsuit is BOGUS — because Kris’ facelift didn’t affect her eyes in any way whatsoever … JUST HER NECK.

Kris’ alleged agreement with B&P went into effect in March 2011 and was to be effective until March 2012 — but Kris admitted … she got the facelift in June.

Quick shot replacing nip, tuck


Injectable use on the rise as a cheaper alternative to cosmetic surgery

Photo from here

A good visit to your plastic surgeon to do some reasonable botox, or fillers is easy. Not something to be afraid of and more people are doing it. Good results are often seen, but on the other hand remember that you can only get so much, o…nly go so far with “minimal” treatments. Don’t expect great results with minimal invasive treatments of any kind. To get the best results, state of the art techniques are needed and these need some down time, have risks, cost money.

Injectable use on the rise as a cheaper alternative to cosmetic surgery

Article from The Chicago Tribune
By Ed Finkel, Special to the Tribune

July 20, 2011

Demand for minimally invasive cosmetic procedures showed a three-digit increase over the last decade, with Botox leading the way for those seeking to look younger or better.

As of last month, would-be patients can consider a new product that uses their own collagen cells, which are multiplied in a lab to create an injectable substance that smoothes out facial features. Injections typically cost a fraction of surgery and require much less recuperation time.

“It’s taking hold. People are doing (injections) a lot more frequently,” said John Bull, a plastic surgeon in Naperville. “People that are looking for a modest improvement with less down time and no scars typically want to have this done. The best candidates are people with early signs of aging and volume loss.”

Laurette Agee, 51, who is general manager of a McDonald’s in Aurora, was a patient of Bull’s. More than four years after losing her husband of 26 years, Agee was ready to come out of her shell but noticed the aging process taking hold.

She did not warm to the idea of plastic surgery, so starting in February she began receiving different types of injections in her cheeks, lips and along the sides of her nostrils.

“I catch men looking at me now in a different perspective. It makes me feel very good,” Agee said. “At my son’s wrestling meets, other moms were like, ‘Did you have something done, Laurette? You look so good.’ I have no shame in saying, ‘I did this, and this, and this.’”

In the last decade, minimally invasive procedures have skyrocketed in popularity, from 5.5 million performed in 2000 to 11.6 million in 2010 — a 110 percent increase, according to the American Society of Plastic Surgeons. The best-known and most commonly used, Botox, jumped 584 percent.

Cosmetic surgical procedures were done 18 percent less often in 2010 than in 2000, with considerably larger drops in facelifts (65 percent), forehead lifts (57 percent), eyelid surgery (36 percent), chin augmentation (55 percent) and nose reshaping (35 percent), the society reports.

The new product, called laViv and approved by the Federal Drug Administration in late June, is what Chicago plastic surgeon Julius Few describes as “another tool in our chest.” It will take awhile to reach market and will be more expensive than other injectables, at least initially, Few said.

“It’s not going to be one of these things where people are going to put down their other options like Botox overnight,” he said. “As this continues to develop and is modified and enhanced as an application, hopefully it will approach a cost point similar to some of the other options and have a broader application. … My experience, given past history, is that the concept of using a patient’s own material and then enriching it is expensive.”

Thomas Mustoe, a plastic surgeon and professor of surgery at Northwestern Memorial Hospital, also expects laViv to be costly and expressed skepticism that it will necessarily work better than other nonsurgical options. He said the FDA approval indicates that the procedure is safe and can work, but patients should not necessarily conclude more.

“This is certainly significant that you have approval,” Mustoe said. “It is going to be simple to inject. But what is unknown is whether it is going to turn out to be better than other fillers. We’re still sorting out what is possible with a needle and an injection.”

Part of the reason for the popularity of injectables is the cost. Bull said they typically are no more than half the cost of surgery, which can run from $5,000 to $20,000, depending upon the areas of the face affected and technique used.

Few said some minimally invasive procedures can cost $3,000 or more. Botox is “a third or less of that,” he said, but needs to be redone every three to six months, while other products can last “on the order of years.” Plastic surgeons have been combining regimens to “get a result that is better than either (product) alone,” he said.

Susan P., 57, a Chicago resident and executive assistant who asked that her last name not be used, has been seeing Few for about four years. He has injected Botox and Restylane around her eyes, the sides of her nose and her forehead, and she estimates she spends about $3,500 per year.

“There’s no giveaway that I’m doing anything, which is really appreciated,” she said. “The longer you do this, the less often you have to go. There’s a cumulative effect.”

Agee estimates she spent a little less than $2,500 for a combination of Radiesse for her cheeks, Botox around her eyes and Juvederm for the sides of her nostrils. Though initially apprehensive about possible side effects, she said, she’s more than willing to repeat it.

“The process was a lot easier than what I anticipated,” she said. She had worried: “My God, what happens if I look like a freak? I work in public nine hours a day. I have like 50 employees under me. I’m going to look like Frankenstein.”

Mustoe said the key to avoiding such results is proper pacing of treatments and not overdoing it.

“Some patients look overly plumped up. There are limits to what you can do,” he said. “You only have to look at the folks in Hollywood to see that a series of (too many) small procedures can have a very strange effect.”

FDA Okays First Autologous Filler for Smile Lines

Article  from here


The US Food and Drug Administration (FDA) late yesterday approved the first autologous aesthetic cell therapy to improve the appearance of moderate to severe nasolabial fold wrinkles in adults.

The product, azficel-T (laVív), is from Fibrocell Science, Inc, a company focused on developing personalized cell therapies for aesthetic, medical, and scientific applications.

According to the company, creating azficel-T involves a patented technology whereby fibroblasts are extracted from behind the patient’s ear and sent to the Fibrocell Science laboratory, where they are multiplied for about 3 months and then frozen until needed.

Azficel-T (laVív). Fibrocell Science Inc

Over a series of 3 treatment sessions, typically 3 to 6 weeks apart, they are injected into nasolabial folds to reduce the appearance of smile lines.

The company says the therapy will become available gradually through trained clinical investigators in select metropolitan areas. As manufacturing capacity is increased and more physicians trained, the number of cities served will expand as well.

The product will be mostly administered by dermatologists and plastic surgeons; only physicians who complete a Fibrocell-approved training program will be able to administer it.

The training program teaches proper biopsy collection and shipment procedures, treatment preparation and injection technique, and logistics tracking to ensure that the cells received by each patient are derived from that same patient.

“Revolutionary” Approach

“The concept of using a patient’s own collagen-making cells is a revolutionary way to help treat nasolabial fold wrinkles and help restore a fresh appearance,” Robert A. Weiss, MD, clinical associate professor, Johns Hopkins School of Medicine, Baltimore, and director of the Maryland Laser Skin and Vein Institute, Hunt Valley, noted in a company-issued statement.

“Since this is a biological process that works over time, [azficel-T] is able to provide gradual and natural-looking results,” noted Dr. Weiss, who participated in clinical trials of azficel-T.

A patient’s nasolabial fold wrinkles before (left) and after (right) azficel-T treatment. Fibrocell Science Inc

This approach is “likely appeal to patients who want to take a very new approach to treating wrinkles,” Stacy Smith, MD, associate clinical professor in the Division of Dermatology at the University of California–San Diego, who also worked on azficel-T clinical trials, said in a statement.

“By injecting tens of millions of the person’s own fibroblasts, patients now have the option to help smooth smile lines by adding cells to replace those that may have been lost through the aging process,” he added.

Babak Azizzadeh, MD, FACS, director of the Center for Advanced Facial Plastic Surgery and assistant clinical professor of facial plastic surgery at University of California–Los Angeles, commented, “It’s an interesting and novel approach that will generate some excitement among physicians and some patients.

“But at the end of the day,” he told Medscape Medical News, “it’s going to depend on whether the results are better than with off-the-shelf injectables, such as Juvederm (Allergan), Restylane (HA North American Sales AB), and Sculptra (Sanofi-Aventis), which are the main competition.”

Dr. Azizzadeh was not involved in the studies of azficel-T and has not treated any patients with it.

He added that “a limiting factor is that the patients have to have a biopsy and then wait 3 months before they get their injections, and then they have to go through a series of treatments. It’s a long process. Physician acceptability, with the length of time involved, may also be an issue.”

2 Pivotal Clinical Trials

The FDA approval was based largely on 2 identical phase 3 multicenter, randomized, double-blind, placebo-controlled studies involving 421 patients who underwent 3 treatment sessions approximately 5 weeks apart.

On the basis of investigators’ and patients’ assessments, a significantly greater proportion of patients demonstrated a positive response to treatment with azficel-T than with placebo, the company notes. The treatment improved the appearance of nasolabial fold wrinkles for the 6 months of patient follow-up after the last treatment. The company said studies are ongoing, looking at how long beyond 6 months after the last treatment the effect may last.

In clinical trials, azficel-T was well tolerated, according to the company. The most common adverse events were mild to moderate injection-site reactions that usually resolved within 1 week. As part of a postmarketing requirement, Fibrocell will set up a registry of approximately 2700 patients to further evaluate the safety of this autologous cell therapy.

TLC for Skin Below the Chin

Article from The American Society for Aesthetic Plastic Surgery

If you’re a woman of a certain age, a glance at your exposed chest may show that you need more than a pushup bra. Women in their fifties begin to show wear in exposed areas. According to the June 2011 issue of More magazine, “Your skin below the chin needs TLC.”

Nora Ephron, author of “I Feel Bad About My Neck” is not alone. Necks are frequently left unprotected with moisturizer and sunscreen. But, if you’re starting to look jowly, there’s a surprising and effective treatment for loose skin under the jawline. A plastic surgeon or dermatologist can skillfully inject Botox into the vertical muscles under your jaw, relaxing them so that they loosen their downward pull on the skin. Cost is $250 and up.

You may also have loose neck skin, sadly but aptly referred to as “turkey neck.” Tighten up before Thanksgiving with Thermage, a skin tightening treatment that uses radio-frequency energy to heat the skin’s deepest layers and stimulate collagenproduction. Cost is about $1,200. You can also boost Thermage effects with Fraxel, a resurfacing laser. If your knees are also sagging, the same skin tighteners used on the neck are also used to lift and tighten this hard-to-fix area.

Your chest, which is so evident in today’s scooped out styles, may be striated with lines and discolored with mottling. Mottling can be treated with glycolic peel laced with retinoic acid for about $100 to $200 a session. Pigment-targeting lasers will take care of your brown spots in about 3 sessions at $350 each. A hyaluronic acidfiller, such as Restylane, could even be used to plump up the lines in your chest for about $500 a treatment.

To prevent further damage, slather your chest with sunscreen, especially in the frequently-exposed clavicle area.


Celebrity Plastic Surgery:  Lynne Curtin from the Real Housewives

Lynne Curtin from The Real Housewives

Is the Improving Economy Causing a Rise in Cosmetic Surgery?

Article from The American Society for Aesthetic Plastic Surgery

Strong correlation between rise in cosmetic procedures and improving economy

While many U.S. citizens are putting off visits to the doctor’s office, there is one sector of medicine that is seeing a surge – plastic surgery. According to medical experts who spoke at the Reuters Health Summit earlier this week, facial aesthetic procedures such as Botox injections are “beyond the peak pre-recession.”

David Pyott, chief executive of Allergan Inc., which makes Botox, remarked that sales of dermal fillers from his company are 20 percent higher than they were before the recession. Cosmetic surgeries hit bottom in 2009, immediately after the housing collapse that caused the large recession.

He added that the increase in demand for Botox could be seen in several different economic brackets, a trend which he believes “correlates with people’s confidence about the future, maybe how much money they have got on their credit card at the time.” Nowadays, visiting a board-certified plastic surgeon for a Botox treatment was similar to spending money on taking the family to a baseball game or small vacation, something that is also indicative of a rebounding economy.

Elective surgeries, such as gastric bypass, are also increasing in number. Weight loss surgery is not something typically prescribed by doctors, so individuals who choose to undergo these procedures likely feel that they have the financial security to do so.

“The bariatrics area is a good one because it shows there are people going back to work full-time, getting insurance, and having the ability to… pay the co-pays that a procedure like that would require,” said Jose Almeida, another representative at the summit. “So that makes us cautiously optimistic about the future.”

The bariatrics trend may in turn lead to more body contouring procedures such as body lifts which aim to reduce the amount of sagging skin that results from a weight loss procedure.

Lower body lifts can help eliminate skin hanging from the stomach and also flatten one’s belly. This will also help lift the thighs and define the buttocks. Typically, this procedure carries a three to four week recovery time, according to the American Society for Aesthetic Plastic Surgery.

Arm lifts, neck lifts and buttocks lifts are all popular forms of surgery that can help with loose skin after weight loss. According to the article, elective procedures are most popular with the middle class and gaining in popularity with the economic rebound.

Back To Top
Call Us: 425-227-4000 Schedule Your Consultation Today With Dr. Santos